We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Strength Seen in Agiliti (AGTI): Can Its 29.1% Jump Turn into More Strength?
Read MoreHide Full Article
Agiliti (AGTI - Free Report) shares soared 29.1% in the last trading session to close at $9.86. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.8% gain over the past four weeks.
Agility scored a strong price increase, on investors’ optimism driven by the announcement that the company has entered into a merger agreement with an affiliate of its majority shareholder, Thomas H. Lee Partners, L.P. (“THL”). THL will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain management shareholders for $10.00 per share in cash, implying an enterprise value of approximately $2.5 billion. The transaction is expected to close in the first half of 2024, subject to customary closing conditions.
This medical equipment services provider is expected to post quarterly earnings of $0.12 per share in its upcoming report, which represents a year-over-year change of -33.3%. Revenues are expected to be $291.99 million, up 3.7% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Agiliti, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AGTI going forward to see if this recent jump can turn into more strength down the road.
Agiliti is a member of the Zacks Medical Services industry. One other stock in the same industry, HealthEquity (HQY - Free Report) , finished the last trading session 1.5% higher at $83.50. HQY has returned 7% over the past month.
For HealthEquity, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.52. This represents a change of +40.5% from what the company reported a year ago. HealthEquity currently has a Zacks Rank of #2 (Buy).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Strength Seen in Agiliti (AGTI): Can Its 29.1% Jump Turn into More Strength?
Agiliti (AGTI - Free Report) shares soared 29.1% in the last trading session to close at $9.86. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.8% gain over the past four weeks.
Agility scored a strong price increase, on investors’ optimism driven by the announcement that the company has entered into a merger agreement with an affiliate of its majority shareholder, Thomas H. Lee Partners, L.P. (“THL”). THL will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain management shareholders for $10.00 per share in cash, implying an enterprise value of approximately $2.5 billion. The transaction is expected to close in the first half of 2024, subject to customary closing conditions.
This medical equipment services provider is expected to post quarterly earnings of $0.12 per share in its upcoming report, which represents a year-over-year change of -33.3%. Revenues are expected to be $291.99 million, up 3.7% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Agiliti, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AGTI going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Agiliti is a member of the Zacks Medical Services industry. One other stock in the same industry, HealthEquity (HQY - Free Report) , finished the last trading session 1.5% higher at $83.50. HQY has returned 7% over the past month.
For HealthEquity, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.52. This represents a change of +40.5% from what the company reported a year ago. HealthEquity currently has a Zacks Rank of #2 (Buy).